Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3247611

View statistics

In Collections

This item can be found in the following collections:

Medicine / Leiden University Medical Centre (LUMC)

Heterologous ad26.COV2.S prime and mRNA-based boost COVID-19 vaccination regimens

Sablerolles, R.S.G.; Goorhuis, A.; GeurtsvanKessel, C.H.; Vries, R.D. de; Huckriede, A.L.W.; Koopmans, M.P.G.; ... ; Kuy, P.H.M. van der (2021)

Heterologous ad26.COV2.S prime and mRNA-based boost COVID-19 vaccination regimens: the SWITCH trial protocol

Article / Letter to editor

Homologous vaccination regimen

Heterologous vaccine regimen

randomized clinical trial

mRNA1273 & nbsp

All authors: Sablerolles, R.S.G.; Goorhuis, A.; GeurtsvanKessel, C.H.; Vries, R.D. de; Huckriede, A.L.W.; Koopmans, M.P.G.; Lafeber, M.; Postma, D.F.; Baarle, D. van; Visser, L.G.; Dalm, V.A.S.H.; Kootstra, N.A.; Rietdijk, W.J.R.; Kuy, P.H.M. van der

Date: 2021-09-24

Journal: Frontiers in Immunology

Volume: 12

DOI: doi:10.3389/fimmu.2021.753319

Link: https://www.frontiersin.org/articles/10.3389/fimmu.2021.753319/pdf